Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avotermin for scar improvement in breast augmentation
NCT00436449Phase 2Completed
- Sponsor
- Renovo
- Start
- Dec 2004
- Primary completion
- Oct 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of avotermin in scarring, sponsored by Renovo. Started Dec 2004; status: completed.
02
Drugs
avotermin
03
Conditions
scarring
Beyond the preview
Go deeper on NCT00436449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00436449.